article thumbnail

Measuring endocrine disruptors in wastewater

Scienmag

Endocrine disruptors are chemicals that alter the hormonal systems and the development of organisms that are exposed to them, even in small quantities. Doctoral student Julie Robitaille and Professor ValĂ©rie Langlois of the Institut national de la recherche scientifique (INRS) are […].

article thumbnail

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

The Pharma Data

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Orgovyx, which was granted Priority Review by the FDA, is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist for men with advanced prostate cancer. Indication.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could Mom’s Thyroid Levels Influence ADHD in Kids?

The Pharma Data

21, 2020 — Low levels of thyroid hormone during pregnancy may contribute to the development of attention deficit hyperactivity disorder in the child, new research suggests. Many of those genes are regulated by thyroid hormones, the team noted. WEDNESDAY, Oct. A number of genes are suspected to be involved in ADHD.

article thumbnail

Genetic biomarkers could personalise therapy for TNBC

Drug Discovery World

The presence of these biomarkers could be used to accelerate the development of more personalised treatments for triple negative breast cancers. Although immune features remained relatively stable, RNA-based features related to DNA damage repair pathways changed significantly.

article thumbnail

Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency

The Pharma Data

Acella’s two drugs are NP Thyroid 15 and NP Thyroid 120, which are sold in 15mg and 120mg strengths, and they contain both the T3 and T4 hormones for those who are able to be treated with synthetic T4 hormone. This follows a similar recall of thyroid medications that was issued by the FDA in recent weeks. Conor Kavanagh.

Drugs 52
article thumbnail

Bayer bags swift OK for Nubeqa in metastatic prostate cancer

pharmaphorum

The US regulator has approved Nubeqa (darolutamide) in combination with docetaxel chemotherapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC), adding to its earlier indication in non-metastatic castration-resistant prostate cancer (nmCRPC). billion) blockbuster.

Sales 59
article thumbnail

Skincare Routines for People with Hidradenitis Suppurativa

Olympian Clinical Research

While the exact cause is unknown, factors like genetics, inflammation, and hormones play a role. Here are some common triggers of HS: Hormonal Changes: Many individuals with HS report flare-ups during periods of hormonal change, such as menstruation, pregnancy, or menopause.